BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33588112)

  • 21. Adequate lung cancer surgery lymphadenectomy within a statewide quality collaborative: Quality improvement in action.
    Kalata S; Lam GT; Alnajjar RM; Clark MJ; He C; Welsh RJ; Chang AC; Lagisetty KH
    J Thorac Cardiovasc Surg; 2023 Jul; 166(1):241-250.e3. PubMed ID: 36456358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adequacy of Intraoperative Nodal Staging during Surgical Resection of NSCLC: Influencing Factors and Its Relationship to Survival.
    Edwards T; Balata H; Elshafi M; Foden P; Bishop P; Fontaine E; Jones M; Krysiak P; Rammohan K; Shah R; Crosbie P; Booton R; Evison M
    J Thorac Oncol; 2017 Dec; 12(12):1845-1850. PubMed ID: 28782727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stage migration: results of lymph node dissection in the era of modern imaging and invasive staging for lung cancer.
    Kirmani BH; Rintoul RC; Win T; Magee C; Magee L; Choong C; Wells FC; Coonar AS
    Eur J Cardiothorac Surg; 2013 Jan; 43(1):104-9; discussion 109-10. PubMed ID: 22529185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection.
    Yendamuri S; Dhillon SS; Groman A; Dy G; Dexter E; Picone A; Nwogu C; Demmy T; Hennon M
    J Thorac Cardiovasc Surg; 2018 Jul; 156(1):394-402. PubMed ID: 29709364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Number of mediastinal lymph nodes in non-small cell lung cancer: a Gaussian curve, not a prognostic factor.
    Riquet M; Legras A; Mordant P; Rivera C; Arame A; Gibault L; Foucault C; Dujon A; Le Pimpec Barthes F
    Ann Thorac Surg; 2014 Jul; 98(1):224-31. PubMed ID: 24820386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival and Resected Lymph Node Number During Sublobar Resection for N0 Non-Small Cell Lung Cancer 2 cm or Less.
    Ding H; Wang H; Xu L; Song N; Jiang G
    Ann Thorac Surg; 2019 Jun; 107(6):1647-1655. PubMed ID: 30682353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic role of station 3A mediastinal nodes for non-small-cell lung cancers.
    Zheng H; Gao W; Fei K; Xie HK; Jiang GN; Ding JA; Li C; Chen C; Zhang L
    Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):447-54. PubMed ID: 23788199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lobe-Specific Lymph Node Dissection as a Standard Procedure in Surgery for Non-Small Cell Lung Cancer: A Propensity Score Matching Study.
    Adachi H; Sakamaki K; Nishii T; Yamamoto T; Nagashima T; Ishikawa Y; Ando K; Yamanaka K; Watanabe K; Kumakiri Y; Tsuboi M; Maehara T; Nakayama H; Masuda M
    J Thorac Oncol; 2017 Jan; 12(1):85-93. PubMed ID: 27553515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is sampling really effective in staging non-small cell lung cancer? A prospective study.
    Magnanelli G; Scanagatta P; Benato C; Terzi A; Lonardoni A; Falezza G; Furlan G; Calabrò F
    Chir Ital; 2006; 58(1):19-22. PubMed ID: 16729605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
    Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
    J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
    Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
    Lardinois D; Suter H; Hakki H; Rousson V; Betticher D; Ris HB
    Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical assessment and intraoperative management of mediastinal lymph nodes in non-small cell lung cancer.
    Whitson BA; Groth SS; Maddaus MA
    Ann Thorac Surg; 2007 Sep; 84(3):1059-65. PubMed ID: 17720443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are discordant positron emission tomography and pathological assessments of the mediastinum in non-small cell lung cancer significant?
    Tandberg DJ; Gee NG; Chino JP; D'Amico TA; Ready NE; Coleman RE; Kelsey CR
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):796-801. PubMed ID: 23870158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upstaging and survival after robotic-assisted thoracoscopic lobectomy for non-small cell lung cancer.
    Toosi K; Velez-Cubian FO; Glover J; Ng EP; Moodie CC; Garrett JR; Fontaine JP; Toloza EM
    Surgery; 2016 Nov; 160(5):1211-1218. PubMed ID: 27665362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical implications of uncertain resection in scenarios of metastasis of the highest or most distant mediastinal lymph node station following surgical treatment of non-small-cell lung cancer.
    Park SY; Byun GE; Lee CY; Lee JG; Kim DJ; Paik HC; Chung KY
    Lung Cancer; 2019 Dec; 138():1-5. PubMed ID: 31593893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non-small cell lung cancer: a large-scale retrospective cohort study applying a propensity score.
    Ishiguro F; Matsuo K; Fukui T; Mori S; Hatooka S; Mitsudomi T
    J Thorac Cardiovasc Surg; 2010 Apr; 139(4):1001-6. PubMed ID: 19733863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term survival after complete mediastinal lymph node resection and lobectomy in patients with bulky N2 non-small cell lung cancer.
    Sakuraba M; Takahashi N; Oh S; Miyasaka Y; Inagaki T; Suzuki K
    Ann Thorac Cardiovasc Surg; 2011; 17(2):124-9. PubMed ID: 21597408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival Implications of Variation in the Thoroughness of Pathologic Lymph Node Examination in American College of Surgeons Oncology Group Z0030 (Alliance).
    Osarogiagbon RU; Decker PA; Ballman K; Wigle D; Allen MS; Darling GE
    Ann Thorac Surg; 2016 Aug; 102(2):363-9. PubMed ID: 27262908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival After Mediastinal Node Dissection, Systematic Sampling, or Neither for Early Stage NSCLC.
    Ray MA; Smeltzer MP; Faris NR; Osarogiagbon RU
    J Thorac Oncol; 2020 Oct; 15(10):1670-1681. PubMed ID: 32574595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.